SCHEMBL31497393

SCHEMBL31497393

CC(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(N)=O)[C@@H](C)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TASP1 Q9H6P5 1/20 0.49
▸ GRIN2D O15399 1/20 0.43
▸ GRIN3B O60391 1/20 0.43
▸ GRIN1 Q05586 1/20 0.43
▸ GRIN2A Q12879 1/20 0.43
▸ GRIN2B Q13224 1/20 0.43
▸ GRIN2C Q14957 1/20 0.43
▸ GRIN3A Q8TCU5 1/20 0.43
▸ SIRT2 Q8IXJ6 1/20 0.43
▸ SIRT5 Q9NXA8 1/20 0.43
▸ KEAP1 Q14145 1/20 0.42
▸ ERBB2 P04626 1/20 0.42
▸ MAGI3 Q5TCQ9 1/20 0.41
▸ BMP1 P13497 1/20 0.41
▸ KISS1R Q969F8 3/20 0.40
▸ BACE1 P56817 1/20 0.40
▸ BACE2 Q9Y5Z0 1/20 0.40
▸ PDCD1LG2 Q9BQ51 1/20 0.40
▸ CD274 Q9NZQ7 1/20 0.40
▸ GNPAT O15228 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31497319 0.94 SIRT2 (0.47) TASP1SIRT2SIRT5KEAP1ERBB2
SCHEMBL31497363 0.93 TASP1 (0.47) TASP1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL31497324 0.92 ERBB2 (0.48) TASP1SIRT2SIRT5KEAP1ERBB2
SCHEMBL31497334 0.92 ERBB2 (0.49) TASP1SIRT2SIRT5KEAP1ERBB2
SCHEMBL31497337 0.91 ERBB2 (0.50) SIRT2SIRT5KEAP1ERBB2BACE1
SCHEMBL31497379 0.90 ERBB2 (0.48) TASP1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL31497322 0.89 BACE1 (0.48) SIRT2SIRT5KEAP1ERBB2BACE1
SCHEMBL31497330 0.89 BACE1 (0.48) TASP1SIRT2SIRT5KEAP1ERBB2
SCHEMBL31497372 0.89 BACE1 (0.48) SIRT2SIRT5KEAP1ERBB2BACE1
SCHEMBL24616816 0.88 GNPAT (0.49) TASP1GRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250388623-A1 PEPTIDE INHIBITOR AND USE THEREOF CHENGDU BRILLIANT INSPIRATION BIOTHERAPEUTICS CO LTD (CN) 2025-12-25 — — US disclosed
EP-4545551-A1 PEPTIDE INHIBITOR AND USE THEREOF Chengdu Brilliant Inspiration Biotherapeutics Co., Ltd (CN) 2025-04-30 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250388623-A1 PEPTIDE INHIBITOR AND USE THEREOF VIP, TGFB1, FN1 TASP1 139/4885GRIN2D 3251/4885GRIN3B 3018/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback